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Our aim is to develop a subunit MAP vaccine not interfering with the diagnosis of 
paratuberculosis or bovine tuberculosis. This study’s objective was to evaluate MAP-specific 
peptides defined by in silico analysis. 
 
Peptides were picked by 1) comparing MAP genomes to that of other mycobacterium 
species or 2) selected based on “experience”. Peptides predicted to bind bovine MHC II by in 
silico analysis were included in further studies, resulting in two panels 1) genome-based and 
2) selected. Initially, two groups of 15 healthy goats were vaccinated with one of the two 
panels (50 µg/peptide in CAF01 adjuvant/CAF04 for boosting). Four MAP-infected goats 
were also vaccinated. In a second vaccination trail, groups of 8 healthy goat kids were 
vaccinated with genome-based peptides, selected peptides or selected peptides linked 
together in a recombinant protein (20 µg/peptide or 50 µg protein in Montanide ISA61 
adjuvant). IFN-γ responses were measured by ELISA and ELISPOT upon stimulation with 
peptide pools or individual peptides. T cell lines were made by cultivating CD4+ cells in the 
presence of antigen, feeder cells plus cytokines, and used to evaluate responses to peptide 
pools and individual peptides. 
 
IFN-γ responses in healthy goats after the first vaccination were low, but testing of T cell 
lines from MAP-infected goats identified peptides inducing strong proliferative responses. 
Peptides for a second vaccination were selected by combining results from this study with a 
parallel cattle study. In the second trial, goats in the genome-based and the selected peptide 
group had solid IFN-γ responses while goats in the protein group had modest responses. 
Only a moderate boosting effect was seen in the second trail. The genome-based pool 
induced the strongest CD4+ T cell line responses and had the highest number of 
immunogenic peptides. 
 
This study shows 1) that detection of immunogenic antigens using in silico predictions and T 
cell lines work, and 2) the identified MAP-specific peptides show potential for use in a 
subunit vaccine.  
  
